Subjective cognitive decline (SCD) or anxiety symptoms in older individuals are independently associated with an increased risk of mild cognitive impairment (MCI) or dementia, a recent study has shown.
Post-infection mortality is higher in older patients with dementia than those without in an analysis of Danish national registry data presented at AAIC 2020.
In patients diagnosed with chronic migraine and medication-overuse headache (MOH), treatment with eptinezumab led to improved patient-reported outcomes, fewer migraine days, and a reduction in acute medication use, according to subgroup analyses of the PROMISE-2* trial presented at AHS 2020.
Calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs) may be associated with a reduced risk of dementia, according to a systematic review and network meta-analysis conducted by researchers from the Netherlands.
Regular influenza and pneumococcal vaccinations may help stave off the development of Alzheimer’s disease (AD), according to two studies presented at AAIC 2020.